Recordati Group
Clinical trials sponsored by Recordati Group, explained in plain language.
-
Doctors track Real-World results of Cushing's syndrome drug over 3 years
Disease control OngoingThis study is observing patients who are already taking the medication osilodrostat for Cushing's syndrome during their regular doctor visits. It aims to collect long-term information on how safe the drug is and how well it controls hormone levels and symptoms over three years. T…
Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New injection tested to stop dangerous sugar crashes after bariatric surgery
Disease control OngoingThis study is testing if an injectable medication called pasireotide can help control severe low blood sugar episodes that sometimes occur after weight-loss surgery. About 93 adults who experience these episodes despite dietary changes will test one of three doses or a placebo fo…
Phase: PHASE2 • Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC